REVIVE A CRM, OR RETHINK THE ONE WE WILL NEED

Three months of immersion with fifteen managers in five countries to revive the adoption of a CRM. The mission led to another outcome: defining the CRM that the company will need in the future, when its role has shifted from diagnosis to therapy.

Sector

 Radiopharmacy

Duration

3 months

Customer team

15 managers and key account managers interviewed, 5 countries

Team Texeï

2 Advisory Consultants

Advice before technology

The group is a world leader in the production and marketing of radiopharmaceutical products: more than 70 countries served, more than 6,000 customers, 15 million patients per year.

Its core business is diagnostics, excluding thyroid treatment and radiosynoviorthesis. In the short term, the company will launch products for the treatment of prostate cancer, which will be a key growth driver for the group globally.

The goal: to revitalize the CRM and accelerate its adoption by key users: key account management, sales management, and branch managers. This relaunch phase comes after the unification of two business units, SPECT and PET.

The objectives are set: to improve performance; to transform a tool perceived as a means of control into a management tool; to centralize data towards a single source of truth and to enhance existing data, in order to avoid the proliferation of unconsolidated Excel files; to improve adoption by all commercial levels; to support the transformation from diagnosis to theranostics.

The group approached the process without preconceived ideas and with little to no knowledge of the "consulting" aspect of an integrator's role. Salesforce suggested Texeï as an option to consider for this consulting: the integrator with whom the group has a contractual agreement has an exclusively technical role and does not offer this type of service.

Two constraints frame the mission: compliance with pharmaceutical regulatory requirements in all EU countries, and the GDPR directive.

The testimonies

“We had no preconceived ideas before starting this journey, nor any specific skills included in our specifications. We started with our problem, and we collaborated with Texeï to precisely define our needs and the questions we absolutely had to answer for a successful relaunch of our CRM.

The outcome is positive: the mission allowed us to go beyond its initial objective and to ask ourselves what the ideal CRM should be to address the transformation towards therapy in the coming years

Pascal Daniel, Strategic Marketing Director, in charge of CRM

"The working relationship was very smooth, collaborative, and regular. It allowed us to adjust the discussion guide according to the type of interlocutor and to review the initial feedback in real time."

"Yes, I would recommend Texeï. And that starts with a good analysis and a good understanding of our business needs and our sector of activity."

The mission's progress

What has changed

A question rephrased

The mission produced the requested recommendation: the key actions to be implemented for a successful CRM launch.

The process led the group to question the future of CRM — what the ideal CRM should be to meet future business needs and address the transformation towards therapy.

The diagnosis produced a mapping of perception gaps, based on an objective analysis of the existing situation.

A multidisciplinary working group was formed to refine the definition of the target CRM and produce an initial internal recommendation. The organization is continuing its analysis using its own resources.